1.Absence of Delayed Neuronal Death in ATP-Injected Brain: Possible Roles of Astrogliosis.
Hey Kyeong JEONG ; Ilo JOU ; Eun Hye JOE
Experimental Neurobiology 2013;22(4):308-314
Although secondary delayed neuronal death has been considered as a therapeutic target to minimize brain damage induced by several injuries, delayed neuronal death does not occur always. In this study, we investigated possible mechanisms that prevent delayed neuronal death in the ATP-injected substantia nigra (SN) and cortex, where delayed neuronal death does not occur. In both the SN and cortex, ATP rapidly induced death of the neurons and astrocytes in the injection core area within 3 h, and the astrocytes in the penumbra region became hypertropic and rapidly surrounded the damaged areas. It was observed that the neurons survived for up to 1-3 months in the area where the astrocytes became hypertropic. The damaged areas of astrocytes gradually reduced at 3 days, 7 days, and 1-3 months. Astrocyte proliferation was detectable at 3-7 days, and vimentin was expressed in astrocytes that surrounded and/or protruded into the damaged sites. The NeuN-positive cells also reappeared in the injury sites where astrocytes reappeared. Taken together, these results suggest that astroycte survival and/or gliosis in the injured brain may be critical for neuronal survival and may prevent delayed neuronal death in the injured brain.
Adenosine Triphosphate
;
Astrocytes
;
Brain Injuries
;
Brain*
;
Gliosis
;
Neurons*
;
Substantia Nigra
;
Vimentin
2.Protein kinase A mediates microglial activation induced by plasminogen and gangliosides.
Kyoung Jin MIN ; Myung Soon YANG ; Ilo JOU ; Eun hye JOE
Experimental & Molecular Medicine 2004;36(5):461-467
In the injured brain, microglia is known to be activated and produce proinflammatory mediators such as interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha) and inducible nitric oxide synthase (iNOS). We investigated the role of protein kinase A (PKA) in microglial activation by both plasminogen and gangliosides in rat primary microglia and in the BV2 immortalized murine microglial cell line. Both plasminogen and gangliosides induced IL-1beta, TNF-alpha and iNOS mRNA expression, and that this expression was inhibited by the addition of the PKA inhibitors, KT5720 and H89. Both plasminogen and gangliosides activated PKA and increased the DNA binding activity of the cAMP response element- binding protein (CREB). Furthermore, KT5720 and H89 reduced the DNA binding activities of CREB and NF-kappaB in plasminogen-treated cells. These results suggest that PKA plays an important role in plasminogen and gangliosides- induced microglial activation.
Animals
;
Carbazoles/pharmacology
;
Cell Line
;
Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors/*physiology
;
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism
;
DNA-Binding Proteins/metabolism
;
Gangliosides/pharmacology/*physiology
;
Gene Expression Regulation
;
Indoles/pharmacology
;
Interleukin-1/genetics
;
Isoquinolines/pharmacology
;
Mice
;
Microglia/drug effects/*enzymology/*immunology
;
NF-kappa B/metabolism
;
Nitric-Oxide Synthase/genetics
;
Plasminogen/pharmacology/*physiology
;
Pyrroles/pharmacology
;
RNA, Messenger/analysis/metabolism
;
Rats
;
Research Support, Non-U.S. Gov't
;
Sulfonamides/pharmacology
;
Tumor Necrosis Factor-alpha/genetics
3.LRRK2 Inhibits FAK Activity by Promoting FERM-mediated Autoinhibition of FAK and Recruiting the Tyrosine Phosphatase, SHP-2.
Insup CHOI ; Ji won BYUN ; Sang Myun PARK ; Ilo JOU ; Eun Hye JOE
Experimental Neurobiology 2016;25(5):269-276
Mutation of leucine-rich repeat kinase 2 (LRRK2) causes an autosomal dominant and late-onset familial Parkinson's disease (PD). Recently, we reported that LRRK2 directly binds to and phosphorylates the threonine 474 (T474)-containing Thr-X-Arg(Lys) (TXR) motif of focal adhesion kinase (FAK), thereby inhibiting the phosphorylation of FAK at tyrosine (Y) 397 residue (pY397-FAK), which is a marker of its activation. Mechanistically, however, it remained unclear how T474-FAK phosphorylation suppressed FAK activation. Here, we report that T474-FAK phosphorylation could inhibit FAK activation via at least two different mechanisms. First, T474 phosphorylation appears to induce a conformational change of FAK, enabling its N-terminal FERM domain to autoinhibit Y397 phosphorylation. This is supported by the observation that the levels of pY397-FAK were increased by deletion of the FERM domain and/or mutation of the FERM domain to prevent its interaction with the kinase domain of FAK. Second, pT474-FAK appears to recruit SHP-2, which is a phosphatase responsible for dephosphorylating pY397-FAK. We found that mutation of T474 into glutamate (T474E-FAK) to mimic phosphorylation induced more strong interaction with SHP-2 than WT-FAK, and that pharmacological inhibition of SHP-2 with NSC-87877 rescued the level of pY397 in HEK293T cells. These results collectively show that LRRK2 suppresses FAK activation through diverse mechanisms that include the promotion of autoinhibition and/or the recruitment of phosphatases, such as SHP-2.
Focal Adhesion Protein-Tyrosine Kinases
;
Glutamic Acid
;
Parkinson Disease
;
Phosphoric Monoester Hydrolases
;
Phosphorylation
;
Phosphotransferases
;
Protein Tyrosine Phosphatase, Non-Receptor Type 11*
;
Threonine
;
Tyrosine*
4.PINK1 Deficiency Decreases Expression Levels of mir-326, mir-330, and mir-3099 during Brain Development and Neural Stem Cell Differentiation.
Insup CHOI ; Joo Hong WOO ; Ilo JOU ; Eun hye JOE
Experimental Neurobiology 2016;25(1):14-23
PTEN-induced putative kinase 1 (PINK1) is a Parkinson's disease (PD) gene. We examined miRNAs regulated by PINK1 during brain development and neural stem cell (NSC) differentiation, and found that lvels of miRNAs related to tumors and inflammation were different between 1-day-old-wild type (WT) and PINK1-knockout (KO) mouse brains. Notably, levels of miR-326, miR-330 and miR-3099, which are related to astroglioma, increased during brain development and NSC differentiation, and were significantly reduced in the absence of PINK1. Interestingly, in the presence of ciliary neurotrophic factor (CNTF), which pushes differentiation of NSCs into astrocytes, miR-326, miR-330, and miR-3099 levels in KO NSCs were also lower than those in WT NSCs. Furthermore, mimics of all three miRNAs increased expression of the astrocytic marker glial fibrillary acidic protein (GFAP) during differentiation of KO NSCs, but inhibitors of these miRNAs decreased GFAP expression in WT NSCs. Moreover, these miRNAs increased the translational efficacy of GFAP through the 3'-UTR of GFAP mRNA. Taken together, these results suggest that PINK1 deficiency reduce expression levels of miR-326, miR-330 and miR-3099, which may regulate GFAP expression during NSC differentiation and brain development.
Animals
;
Astrocytes
;
Astrocytoma
;
Brain*
;
Ciliary Neurotrophic Factor
;
Glial Fibrillary Acidic Protein
;
Inflammation
;
Mice
;
MicroRNAs
;
Neural Stem Cells*
;
Parkinson Disease
;
Phosphotransferases
;
RNA, Messenger
5.Suppression of miR-155 Expression in IFN-gamma-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.
Jong Hyeon KIM ; Ilo JOU ; Eun Hye JOE
Experimental Neurobiology 2014;23(2):148-154
Previously, we reported that DJ-1, encoded by a Parkinson's disease (PD)-associated gene, inhibits expression of proinflammatory mediators in interferon-gamma (IFN-gamma)-treated astrocytes and microglia through inhibition of STAT1 activation. Here, using microglia and astrocytes cultured from wild-type (WT) and DJ-1-knockout (KO) mouse brains, we examined how DJ-1 regulates suppressor of cytokine signaling 1 (SOCS1), a negative feedback regulator of STAT1 (signal transducer and activator of transcription) that is also induced by STAT1. We found that IFN-gamma significantly increased SOCS1 mRNA expression in WT microglia and astrocytes, but not in KO cells, although STAT1 was highly activated in these latter cells. We further found that SOCS mRNA stability was decreased in DJ-1-KO cells, an effect that appeared to be mediated by the microRNA, miR-155. IFN-gamma increased the levels of miR-155 in DJ-1-KO cells but not in WT cells. In addition, an miR-155 inhibitor rescued SOCS1 expression and decreased STAT1 activation in DJ-1-KO cells. Taken together, these results suggest that DJ-1 efficiently regulates inflammation by maintaining SOCS1 expression through regulation of miR-155 levels, even under conditions in which STAT1 activation is decreased.
Animals
;
Astrocytes*
;
Brain
;
Inflammation
;
Interferon-gamma
;
Mice
;
Microglia*
;
MicroRNAs
;
Parkinson Disease
;
RNA Stability
;
RNA, Messenger
;
Transducers
6.Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra.
Hey Kyeong JEONG ; Ilo JOU ; Eun hye JOE
Experimental & Molecular Medicine 2010;42(12):823-832
It has been suggested that brain inflammation is important in aggravation of brain damage and/or that inflammation causes neurodegenerative diseases including Parkinson's disease (PD). Recently, systemic inflammation has also emerged as a risk factor for PD. In the present study, we evaluated how systemic inflammation induced by intravenous (iv) lipopolysaccharides (LPS) injection affected brain inflammation and neuronal damage in the rat. Interestingly, almost all brain inflammatory responses, including morphological activation of microglia, neutrophil infiltration, and mRNA/protein expression of inflammatory mediators, appeared within 4-8 h, and subsided within 1-3 days, in the substantia nigra (SN), where dopaminergic neurons are located. More importantly, however, dopaminergic neuronal loss was not detectable for up to 8 d after iv LPS injection. Together, these results indicate that acute induction of systemic inflammation causes brain inflammation, but this is not sufficiently toxic to induce neuronal injury.
Animals
;
Astrocytes/pathology
;
Cell Death
;
Encephalitis/chemically induced/immunology/*pathology
;
Injections, Intravenous
;
Lipopolysaccharides/*pharmacology
;
Male
;
Microglia/pathology
;
Neutrophil Infiltration
;
Rats
;
Rats, Sprague-Dawley
;
Substantia Nigra/immunology/*pathology
7.Astrocytes, Microglia, and Parkinson's Disease.
Eun Hye JOE ; Dong Joo CHOI ; Jiawei AN ; Jin Hwa EUN ; Ilo JOU ; Sangmyun PARK
Experimental Neurobiology 2018;27(2):77-87
Astrocytes and microglia support well-being and well-function of the brain through diverse functions in both intact and injured brain. For example, astrocytes maintain homeostasis of microenvironment of the brain through up-taking ions and neurotransmitters, and provide growth factors and metabolites for neurons, etc. Microglia keep surveying surroundings, and remove abnormal synapses or respond to injury by isolating injury sites and expressing inflammatory cytokines. Therefore, their loss and/or functional alteration may be directly linked to brain diseases. Since Parkinson's disease (PD)-related genes are expressed in astrocytes and microglia, mutations of these genes may alter the functions of these cells, thereby contributing to disease onset and progression. Here, we review the roles of astrocytes and microglia in intact and injured brain, and discuss how PD genes regulate their functions.
Astrocytes*
;
Brain
;
Brain Diseases
;
Cytokines
;
Homeostasis
;
Intercellular Signaling Peptides and Proteins
;
Ions
;
Microglia*
;
Neurons
;
Neurotransmitter Agents
;
Parkinson Disease*
;
Synapses
8.PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices.
Jun KIM ; Ji Won BYUN ; Insup CHOI ; Beomsue KIM ; Hey Kyeong JEONG ; Ilo JOU ; Eunhye JOE
Experimental Neurobiology 2013;22(1):38-44
Parkinson's disease (PD) is the second most common neurodegenerative motor disease caused by degeneration of dopaminergic neurons in the substantia nigra. Because brain inflammation has been considered a risk factor for PD, we analyzed whether PTEN induced putative kinase 1 (PINK1), an autosomal recessive familial PD gene, regulates brain inflammation during injury states. Using acutely prepared cortical slices to mimic injury, we analyzed expression of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin (IL)-1beta, and IL-6 at the mRNA and protein levels. Both mRNA and protein expression of these cytokines was higher at 6-24 h after slicing in PINK1 knockout (KO) slices compared to that in wild-type (WT) slices. In serial experiments to understand the signaling pathways that increase inflammatory responses in KO slices, we found that IkappaB degradation was enhanced but Akt phosphorylation decreased in KO slices compared to those in WT slices. In further experiments, an inhibitor of PI3K (LY294002) upstream of Akt increased expression of pro-inflammatory cytokines. Taken together, these results suggest that PINK1 deficiency enhance brain inflammation through reduced Akt activation and enhanced IkappaB degradation in response to brain injury.
Brain
;
Brain Injuries
;
Cytokines
;
Dopaminergic Neurons
;
Encephalitis
;
Hydrazines
;
Inflammation
;
Interleukin-6
;
Interleukins
;
Parkinson Disease
;
Phosphorylation
;
Phosphotransferases
;
Risk Factors
;
RNA, Messenger
;
Substantia Nigra
;
Tumor Necrosis Factor-alpha
9.Control of Inflammatory Responses: a New Paradigm for the Treatment of Chronic Neuronal Diseases.
Joo Hong WOO ; Jee Hoon LEE ; Hyunmi KIM ; Soo Jung PARK ; Eun hye JOE ; Ilo JOU
Experimental Neurobiology 2015;24(2):95-102
The term 'inflammation' was first introduced by Celsus almost 2000 years ago. Biological and medical researchers have shown increasing interest in inflammation over the past few decades, in part due to the emerging burden of chronic and degenerative diseases resulting from the increased longevity that has arisen thanks to modern medicine. Inflammation is believed to play critical roles in the pathogenesis of degenerative brain diseases, including Alzheimer's disease and Parkinson's disease. Accordingly, researchers have sought to combat such diseases by controlling inflammatory responses. In this review, we describe the endogenous inflammatory stimulators and signaling pathways in the brain. In particular, our group has focused on the JAK-STAT pathway, identifying anti-inflammatory targets and testing the effects of various anti-inflammatory drugs. This work has shown that the JAK-STAT pathway and its downstream are negatively regulated by phosphatases (SHP2 and MKP-1), inhibitory proteins (SOCS1 and SOCS3) and a nuclear receptor (LXR). These negative regulators are controlled at various levels (e.g. transcriptional, post-transcriptional and post-translational). Future study of these proteins could facilitate the manipulation of the inflammatory response, which plays ubiquitous, diverse and ambivalent roles under physiological and pathological conditions.
Alzheimer Disease
;
Brain
;
Brain Diseases
;
History, Modern 1601-
;
Inflammation
;
Longevity
;
Neurons*
;
Parkinson Disease
;
Phosphoric Monoester Hydrolases
10.Phosphatidylinositol 4-phosphate 5-kinase alpha is induced in ganglioside-stimulated brain astrocytes and contributes to inflammatory responses.
Sang Yoon LEE ; Bokyung KIM ; Sarah YOON ; Yeon Joo KIM ; Tian LIU ; Joo Hong WOO ; Yong Joon CHWAE ; Eun hye JOE ; Ilo JOU
Experimental & Molecular Medicine 2010;42(9):662-673
In brain tissue, astrocytes play defensive roles in central nervous system integrity by mediating immune responses against pathological conditions. Type I phosphatidylinositol 4-phosphate 5-kinase alpha (PIP5Kalpha) that is responsible for production of phosphatidylinositol 4,5-bisphosphate (PI[4,5]P2) regulates many important cell functions at the cell surface. Here, we have examined whether PIP5Kalpha is associated with astrocyte inflammatory responses. Gangliosides are releasable from damaged cell membranes of neurons and capable of inducing inflammatory responses. We found that treatment of primary cultured astrocytes with gangliosides significantly enhanced PIP5Kalpha mRNA and protein expression levels. PI(4,5)P2 imaging using a fluorescent tubby (R332H) expression as a PI(4,5)P2-specific probe showed that ganglioside treatment increased PI(4,5)P2 level. Interestingly, microRNA-based PIP5Kalpha knockdown strongly reduced ganglioside-induced transcription of proinflammatory cytokines IL-1beta and TNFalpha. PIP5Kalpha knockdown also suppressed ganglioside-induced phosphorylation and nuclear translocation of NF-kappaB and the degradation of IkappaB-alpha, indicating that PIP5Kalpha knockdown interfered with the ganglioside-activated NF-kappaB signaling. Together, these results suggest that PIP5Kalpha is a novel inflammatory mediator that undergoes upregulation and contributes to immune responses by facilitating NF-kappaB activation in ganglioside-stimulated astrocytes.
Animals
;
Astrocytes/*metabolism
;
Cells, Cultured
;
Gangliosides/*metabolism
;
Gene Knockdown Techniques
;
Inflammation/*metabolism
;
Interleukin-1/metabolism
;
NF-kappa B/metabolism
;
Phosphotransferases (Alcohol Group Acceptor)/*metabolism
;
RNA, Messenger/*genetics/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Signal Transduction
;
Tumor Necrosis Factor-alpha/metabolism
;
Up-Regulation